Activ Surgical, a pioneering digital intelligence company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility, today announced the close of an additional $11 million from Series A round funding. The financing was led by DNS Capital, and will allow the company to accelerate commercialization of its proprietary, software-centric and hardware agnostic technology. Other investors in the round include GreatPoint Ventures (GPV), Tao Capital Partners, SONY Innovation Fund, Rising Tide Financial, WS Investment Company and Mintz.
"The enthusiasm and level of support from a diverse group of investors validates our unique and proprietary technology," commented Todd Usen, Chief Executive Officer, Activ Surgical. "The funding will be used to continue to grow the organization and prepare for the 2020 launch of ActivSight, an advanced software and sensing platform that will provide clinicians around the world with intraoperative visual data and images not currently available through existing technologies."
Michael Pucker, Chairman and CEO of DNS Capital, said, "Activ Surgical's integration of advanced imaging technology and artificial intelligence positions the company to have an enormous impact on the future of healthcare by improving patient outcomes, reducing healthcare costs, and addressing unintended surgical complications. We look forward to working closely with the experienced Activ Surgical team and the company's other investors to support their long-term growth plans."
Series A financing was led by an entity advised by DNS Capital, LLC.
About DNS Capital DNS Capital is the private investment office for Gigi Pritzker Pucker, Michael Pucker and their immediate family. DNS Capital takes a long-term and flexible approach to investing, and focuses on people, relationships and culture. For more information, visit www.dnscap.com.
About Activ Surgical Founded in 2017, Activ Surgical is a first-of-its kind digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility for both endoscopic and robotically-assisted procedures. Activ Surgical's scalable and patent-protected surgical software platform technology is driven by computer vision, artificial intelligence, analytics and machine learning to enhance a surgeon's intra-operative decision making, and reduce unintended and preventable surgical complications.
